Relapsed/Refractory Multiple Myeloma: Multidisciplinary Care and Caregiver Support

Dr. Joshua Richter and Dr. Marco Davila discuss the essential role of multidisciplinary care and caregiver engagement in the management of relapsed/refractory multiple myeloma (RRMM), particularly for patients undergoing CAR T-cell therapy. Dr. Davila emphasizes that caregivers are integral members of the treatment team, helping monitor for delayed toxicities and supporting patients throughout recovery. He describes a comprehensive educational approach that includes written resources, structured teaching sessions, and repeated discussions during clinic visits to reinforce key information for both patients and caregivers. The conversation also highlights the importance of collaboration among physicians, advanced practice providers, nurses, pharmacists, transplant coordinators, and referring oncologists to address clinical and logistical challenges. Dr. Davila explains that specialized treatment centers can often overcome barriers such as limited caregiver availability through individualized care planning, reinforcing that early referral and multidisciplinary coordination are critical to ensuring eligible patients can successfully receive cellular therapy and achieve the best possible outcomes in RRMM.